Weakly Supervised Detection of Pheochromocytomas and Paragangliomas in CT
David C. Oluigboa, Bikash Santra, Tejas Sudharshan Mathai, Pritam Mukherjee, Jianfei Liu, Abhishek Jha, Mayank Patel, Karel Pacak, Ronald M. Summers
TL;DR
This work tackles the challenge of detecting pheochromocytomas and paragangliomas (PPGLs) in CT scans using weak annotations. It introduces a proxy segmentation framework where 2D radiologist-marked boxes are expanded to weak 3D masks and combined with body-region segmentation, trained with a 3D full-resolution nnUNet. The method achieves a precision of $62.4 ext{ extpercent}$ and recall of $64.1 ext{ extpercent}$ without size filtering, improving to $70.0 ext{ extpercent}$ precision when excluding small predictions, with a patient-level recall of $100 ext{ extpercent}$ and median precision up to $84.9 ext{ extpercent}$. This pilot demonstrates the feasibility of weakly supervised PPGL detection in CT and paves the way for more efficient, automated monitoring of PPGLs in clinical workflows, albeit with limitations such as ground-truth bias and lack of genetic stratification.
Abstract
Pheochromocytomas and Paragangliomas (PPGLs) are rare adrenal and extra-adrenal tumors which have the potential to metastasize. For the management of patients with PPGLs, CT is the preferred modality of choice for precise localization and estimation of their progression. However, due to the myriad variations in size, morphology, and appearance of the tumors in different anatomical regions, radiologists are posed with the challenge of accurate detection of PPGLs. Since clinicians also need to routinely measure their size and track their changes over time across patient visits, manual demarcation of PPGLs is quite a time-consuming and cumbersome process. To ameliorate the manual effort spent for this task, we propose an automated method to detect PPGLs in CT studies via a proxy segmentation task. As only weak annotations for PPGLs in the form of prospectively marked 2D bounding boxes on an axial slice were available, we extended these 2D boxes into weak 3D annotations and trained a 3D full-resolution nnUNet model to directly segment PPGLs. We evaluated our approach on a dataset consisting of chest-abdomen-pelvis CTs of 255 patients with confirmed PPGLs. We obtained a precision of 70% and sensitivity of 64.1% with our proposed approach when tested on 53 CT studies. Our findings highlight the promising nature of detecting PPGLs via segmentation, and furthers the state-of-the-art in this exciting yet challenging area of rare cancer management.
